[Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa].
Replacement therapy of coagulation factor preparations (AT, FFP, PPSB, FXIII, rFVIIa) are frequently used on the Intensive Care Units. Indications, dosage, specific effects and side effects have to be considered.
Scharrer
I
I
Abt. für Hämostaseologie, J.W.-Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt am Main. Scharrer@em.uni-frankfurt.de
D000991:Antithrombins / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use*; D005176:Factor XIII / Q000627:therapeutic use*; D006801:Humans; D010949:Plasma; D011994:Recombinant Proteins / Q000627:therapeutic use
D000991:Antithrombins; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; C025667:prothrombin complex concentrates; D005176:Factor XIII; D015942:Factor VIIa